Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides derived from the protein MMP-2, and the use thereof in antitumoral immunotherapy

Peptides derived from the protein MMP-2, and the use thereof in antitumoral immunotherapy

US Patent 7629439 · Granted Dec 8, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnosis, prognosis and treatment of a disease related to a decrease of F. prau2025
Diagnosis, prognosis and treatment of a disease related to a decrease of F. prau2025
Methods, agents and peptides for inhibiting matrix metalloproteinase-2 signaling2017
Methods, agents and peptides for inducing an immune response to matrix metallopr2016
Methods, agents and peptides for inducing an immune response to matrix metallopr2016
Methods, agents and peptides for inducing an immune response to matrix metallopr2013
Methods, agents and peptides for inducing an immune response to matrix metallopr2013
Methods for determining expression of NAG tumor rejection antigen precursor1999
Methods for determining expression of NAG tumor rejection antigen precursor1999
Isolated nucleic acid molecules, peptides which form complexes with MHC molecule1999
Isolated nucleic acid molecules, peptides which form complexes with MHC molecule1999
Isolated nucleic acid molecules, peptides which form complexes with MHC molecule1998